Comparison

Cemiplimab European Partner

€945.00
Excl. VAT
Item no. HY-P99203-10mg
Manufacturer MedChem Express
CASRN 1801342-60-8
Amount 10 mg
Category
Type Inhibitors
Specific against other
Purity 99.89
Dry ice Yes
Citations [1]Michael R Migden, et al. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2018 Jul 26;379(4):341-351.
[2]Elena Burova, et al. Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice. Mol Cancer Ther. 2019 Nov;18(11):2051-2062.
Smiles [Cemiplimab]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research[1][2].
StorageTemperature
Store at -80°C for 2 years
Shipping
Dry Ice
Manufacturers Applications
Cancer-programmed cell death
Molecular Weight
N/A
Clinical Information
Launched
Solubility
10 mM in DMSO
Pathway
Immunology/Inflammation
Manufacturers Product type
Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
Listprice: €945.00
Price: €945.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close